Back to investors
SATURN V CAPITAL MANAGEMENT LLC
SATURN V CAPITAL MANAGEMENT LLC
Latest filing: 2026-06-30
SATURN V CAPITAL MANAGEMENT LLC runs SATURN V CAPITAL MANAGEMENT LLC and currently holds 23 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $697.47M. Their top holdings are AMLX, ALMS, ABVX, PCVX, PHVS. The top five represent 47.2% of reported portfolio weight. SATURN V CAPITAL MANAGEMENT LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, SATURN V CAPITAL MANAGEMENT LLC initiated 2 new positions. They added to 6 existing positions. They trimmed 3 positions. Their current best-performing preview position is AMLX with returns of +29.21%.
Sign in to enable email alerts for this investor.
Showper page
23 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 AMLX AMYLYX PHARMACEUTICALS INC | 11.91% | $7.69 | $38.66 | +402.73% | Added +6.30% |
 ALMS ALUMIS INC | 11.76% | $10.01 | $24.17 | +141.46% | Trimmed -8.95% |
 ABVX ABIVAX SA | 9.91% | $29.16 | $114.95 | +294.20% | Trimmed -4.39% |
 PCVX VAXCYTE INC | 7.11% | $44.02 | $62.62 | +42.25% | Added +3.44% |
 PHVS PHARVARIS N V | 6.52% | $26.47 | $36.27 | +37.02% | Added +9.38% |
 JAZZ JAZZ PHARMACEUTICALS PLC | 5.56% | $114.12 | $254.28 | +122.82% | Trimmed -1.24% |
 CELC CELCUITY INC | 5.55% | $36.85 | $93.53 | +153.81% | Added +31.36% |
 IRON DISC MEDICINE INC | 5.50% | $53.62 | $79.81 | +48.84% | Added +16.63% |
 DYN DYNE THERAPEUTICS INC | 3.37% | $11.91 | $26.10 | +119.14% | Added +9.40% |
 TRVI TREVI THERAPEUTICS INC | 2.81% | $18.65 | $17.96 | -3.70% | New Buy |
Showing 1-10 of 23